Search Results - "Nacmias, B."

Refine Results
  1. 1
  2. 2

    EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia by Sorbi, S., Hort, J., Erkinjuntti, T., Fladby, T., Gainotti, G., Gurvit, H., Nacmias, B., Pasquier, F., Popescu, B. O., Rektorova, I., Religa, D., Rusina, R., Rossor, M., Schmidt, R., Stefanova, E., Warren, J. D., Scheltens, P.

    Published in European journal of neurology (01-09-2012)
    “…Background and objectives The last version of the EFNS dementia guidelines is from 2007. In 2010, the revised guidelines for Alzheimer's disease (AD) were…”
    Get full text
    Journal Article
  3. 3

    Assessing the effectiveness of subjective cognitive decline plus criteria in predicting the progression to Alzheimer’s disease: an 11‐year follow‐up study by Mazzeo, S., Padiglioni, S., Bagnoli, S., Carraro, M., Piaceri, I., Bracco, L., Nacmias, B., Sorbi, S., Bessi, V.

    Published in European journal of neurology (01-05-2020)
    “…Background and purpose Subjective cognitive decline (SCD) is a self‐experienced decline in cognitive capacity with normal performance on standardized cognitive…”
    Get full text
    Journal Article
  4. 4

    Long-term use of pharmacological treatment in Alzheimer’s disease: a retrospective cohort study in real-world clinical practice by Lombardi, G, Lombardi, N, Bettiol, A, Crescioli, G, Ferrari, C, Lucidi, G, Polito, C, Berti, V, Bessi, V, Bagnoli, S, Nacmias, B, Vannacci, A, Sorbi, S

    Published in European journal of clinical pharmacology (01-07-2022)
    “…Purpose To assess the impact of long-term use of different drugs commonly prescribed in Alzheimer’s disease (AD) on its clinical course and to identify…”
    Get full text
    Journal Article
  5. 5

    PER2 C111G polymorphism, cognitive reserve and cognition in subjective cognitive decline and mild cognitive impairment: a 10‐year follow‐up study by Bessi, V., Giacomucci, G., Mazzeo, S., Bagnoli, S., Padiglioni, S., Balestrini, J., Tomaiuolo, G., Piaceri, I., Carraro, M., Bracco, L., Sorbi, S., Nacmias, B.

    Published in European journal of neurology (01-01-2021)
    “…Clock genes have been implicated in sleep‐wake cycle alterations and neurodegenerative diseases, but the role of PER2 C111G on cognition and on the risk of…”
    Get full text
    Journal Article
  6. 6

    MCI conversion to dementia and the APOE genotype: A prediction study with FDG-PET by MOSCONI, L, PERANI, D, BORRONI, B, FRANCESCHI, M, BRACCO, L, PUPI, A, SORBI, S, HERHOLZ, K, NACMIAS, B, HOLTHOFF, V, SALMON, E, BARON, J.-C, DE CRISTOFARO, M. T. R, PADOVANI, A

    Published in Neurology (28-12-2004)
    “…To investigate whether the combination of fluoro-2-deoxy-d-glucose (FDG) PET measures with the APOE genotype would improve prediction of the conversion from…”
    Get full text
    Journal Article Web Resource
  7. 7

    Incomplete penetrance in familial Alzheimer’s disease with PSEN1 Ala260Gly mutation by Piaceri, I., Chiari, A., Galli, C., Bagnoli, S., Ferrari, C., Saavedra, S. Trujillo, Molinari, M. A., Vinceti, G., Sorbi, S., Nacmias, B.

    Published in Neurological sciences (01-08-2020)
    “…Presenilin1 (PSEN1) gene is the most common known genetic cause of early-onset familial Alzheimer’s disease. We describe an Italian family with the known…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Alzheimer's disease: genetic basis and amyloid imaging as endophenotype by Berti, V, Nacmias, B, Bagnoli, S, Sorbi, S

    “…To date, all known Alzheimer's disease genes influence amyloid β (Aβ). Imaging of Aβ deposition in the human brain using positron emission tomography (PET)…”
    Get full text
    Journal Article
  10. 10

    Clinical heterogeneity in Italian patients with amyotrophic lateral sclerosis by Piaceri, I, Del Mastio, M, Tedde, A, Bagnoli, S, Latorraca, S, Massaro, F, Paganini, M, Corrado, A, Sorbi, S, Nacmias, B

    Published in Clinical genetics (01-07-2012)
    “…Piaceri I, Del Mastio M, Tedde A, Bagnoli S, Latorraca S, Massaro F, Paganini M, Corrado A, Sorbi S, Nacmias B. Clinical heterogeneity in Italian patients with…”
    Get full text
    Journal Article
  11. 11

    The different apoptotic potential of the p53 codon 72 alleles increases with age and modulates in vivo ischaemia-induced cell death by Bonafé, M, Salvioli, S, Barbi, C, Trapassi, C, Tocco, F, Storci, G, Invidia, L, Vannini, I, Rossi, M, Marzi, E, Mishto, M, Capri, M, Olivieri, F, Antonicelli, R, Memo, M, Uberti, D, Nacmias, B, Sorbi, S, Monti, D, Franceschi, C

    Published in Cell death and differentiation (01-09-2004)
    “…A common arginine to proline polymorphism is harboured at codon 72 of the human p53 gene. In this investigation, we found that fibroblasts and lymphocytes…”
    Get full text
    Journal Article
  12. 12

    Early structural changes in individuals at risk of familial Alzheimer’s disease: a volumetry and magnetization transfer MR imaging study by Ginestroni, A., Battaglini, M., Della Nave, R., Moretti, M., Tessa, C., Giannelli, M., Caffarra, P., Nacmias, B., Bessi, V., Sorbi, S., Bracco, L., De Stefano, N., Mascalchi, M.

    Published in Journal of neurology (01-06-2009)
    “…Presenilin 1 (PS1) mutation carriers provide the opportunity to asses early features of neurodegeneration in familial Alzheimer’s disease (AD). Gray matter…”
    Get full text
    Journal Article
  13. 13

    Metabolic interaction between ApoE genotype and onset age in Alzheimer’s disease: implications for brain reserve by Mosconi, L, Herholz, K, Prohovnik, I, Nacmias, B, De Cristofaro, M T R, Fayyaz, M, Bracco, L, Sorbi, S, Pupi, A

    “…Background: Clinically apparent Alzheimer’s disease (AD) is thought to result when brain tissue damage exceeds a critical threshold of “brain reserve”, a…”
    Get full text
    Journal Article
  14. 14

    Alzheimer's disease: role of size and location of white matter changes in determining cognitive deficits by Bracco, L, Piccini, C, Moretti, M, Mascalchi, M, Sforza, A, Nacmias, B, Cellini, E, Bagnoli, S, Sorbi, S

    Published in Dementia and geriatric cognitive disorders (01-01-2005)
    “…This study investigated the contribution that white matter changes (WMCs) make to clinical and cognitive features in Alzheimer's disease (AD), independently of…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Codon 129 polymorphism of prion protein gene in sporadic Alzheimer's disease by Poleggi, A., Bizzarro, A., Acciarri, A., Antuono, P., Bagnoli, S., Cellini, E., Forno, G. Dal, Giannattasio, C., Lauria, A., Matera, M. G., Nacmias, B., Puopolo, M., Seripa, D., Sorbi, S., Wekstein, D. R., Pocchiari, M., Masullo, C.

    Published in European journal of neurology (01-02-2008)
    “…Codon 129 polymorphism of the prion protein gene represents a major genetic risk factor for Creutzfeldt‐Jakob disease (CJD). Both CJD and Alzheimer’s disease…”
    Get full text
    Journal Article
  17. 17

    ApolipoproteinE epsilon 4 allele is not associated with disease course and severity in multiple sclerosis by Portaccio, E., Zipoli, V., Goretti, B., Hakiki, B., Nacmias, B., Siracusa, G., Sorbi, S., Amato, M. P.

    Published in Acta neurologica Scandinavica (01-12-2009)
    “…Background –  No study has assessed the association between apolipoproteinE (APOE) and multiple sclerosis (MS) forms grouped by also taking into account…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    P02-64 Glucocorticoid receptor gene polymorphisms in Italian patients with anorexia and bulimia nervosa by Nacmias, B, Cellini, E, Ricca, V, Castellini, G, Tedde, A, Bagnoli, S, Sorbi, S

    Published in European psychiatry (2009)
    “…The etiopathogenesis of eating disorders (ED) is complex and poorly understood. The hypothalamic-pituitary-adrenal (HPA) axis, involved in the biological…”
    Get full text
    Journal Article